Global Pharma and Health Care Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Pharma and Health Care Market 2024 by Company, Regions, Type and Application, Forecast to 2030

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

According to our (Global Info Research) latest study, the global Pharma and Health Care market size was valued at US$ 1337580 million in 2023 and is forecast to a readjusted size of USD 1743920 million by 2030 with a CAGR of 3.9% during review period.

North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.

This report is a detailed and comprehensive analysis for global Pharma and Health Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Format and by Prescription. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Pharma and Health Care market size and forecasts, in consumption value ($ Million), 2019-2030

Global Pharma and Health Care market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Pharma and Health Care market size and forecasts, by Format and by Prescription, in consumption value ($ Million), 2019-2030

Global Pharma and Health Care market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pharma and Health Care

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharma and Health Care market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Pharma and Health Care market is split by Format and by Prescription. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Format and by Prescription. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Pharma and Health Care market is split by Format and by Prescription. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Format and by Prescription. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Format
Bottle
Blister
Others

Market segment by Prescription
OTC Drugs
Prescription Drugs

Market segment by players, this report covers
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Pharma and Health Care product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Pharma and Health Care, with revenue, gross margin, and global market share of Pharma and Health Care from 2019 to 2024.

Chapter 3, the Pharma and Health Care competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Format and by Prescription, with consumption value and growth rate by Format, by Prescription, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharma and Health Care market forecast, by regions, by Format and by Prescription, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Pharma and Health Care.

Chapter 13, to describe Pharma and Health Care research findings and conclusion.